| P50 | author | Lyn Griffiths | Q30506525 |
| | Evelin Tiralongo | Q87495064 |
| P2093 | author name string | E Tiralongo | |
| | M M Hanna | |
| | R A Lea | |
| | S S Wee | |
| P2860 | cites work | Echinacea for preventing and treating the common cold | Q24244680 |
| | Echinacea for prevention of the common cold: an illustrative overview of how information from different systematic reviews is summarised on the internet | Q28242333 |
| | Echinacea for preventing and treating the common cold | Q28264254 |
| | Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects | Q28302804 |
| | Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis | Q28307738 |
| | ABC of complementary medicine. Users and practitioners of complementary medicine | Q33738322 |
| | Respiratory infections during air travel. | Q34387510 |
| | The safety of herbal medicinal products derived from Echinacea species: a systematic review | Q34413871 |
| | Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties | Q34443230 |
| | Perception of cabin air quality in airline crew related to air humidification, on intercontinental flights. | Q50990228 |
| | Complementary and alternative medicine use in Australia: a national population-based survey. | Q51105051 |
| | Changes in ocular and nasal signs and symptoms among air crew in relation to air humidification on intercontinental flights. | Q51208683 |
| | Relations among questionnaire and laboratory measures of rhinovirus infection. | Q53247585 |
| | How should the minimum important difference for a health-related quality-of-life instrument be estimated? | Q53473480 |
| | Complementary and Alternative Medicine Use in Canada and the United States | Q59150155 |
| | Comparison of Echinacea alkylamide pharmacokinetics between liquid and tablet preparations | Q79749042 |
| | Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans | Q80607084 |
| | Echinacea intake induces an immune response through altered expression of leucocyte hsp70, increased white cell counts and improved erythrocyte antioxidant defences | Q81900775 |
| | Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells | Q83818197 |
| | Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters | Q34602400 |
| | Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection | Q34607537 |
| | Echinacea for treating the common cold: a randomized trial | Q34665639 |
| | Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety | Q35101633 |
| | Lack of herbal supplement characterization in published randomized controlled trials | Q36272299 |
| | Allergic rhinitis and ear pain in flight | Q36310025 |
| | Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. | Q36470152 |
| | The effect of Echinacea on upper respiratory infection symptom severity and quality of life. | Q36503633 |
| | Enhancement of innate and adaptive immune functions by multiple Echinacea species | Q36617061 |
| | Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation. | Q37157352 |
| | Clinical effects of rhinovirus infections | Q37286561 |
| | Medical issues associated with commercial flights | Q37397935 |
| | Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. | Q37654630 |
| | Risks of travel, benefits of a specialist consult | Q37723111 |
| | Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract | Q39857810 |
| | The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold. | Q40583621 |
| | Air travel and respiratory disease | Q42780617 |
| | Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I). | Q43605056 |
| | A standardized Echinacea extract demonstrates efficacy in the prevention and treatment of colds in athletes | Q45153627 |
| | Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion | Q46512377 |
| | The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid | Q47801206 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | placebo | Q269829 |
| | placebo-controlled trial | Q108853737 |
| P304 | page(s) | 417267 | |
| P577 | publication date | 2011-12-20 | |
| P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
| P1476 | title | Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellers | |
| P478 | volume | 2012 | |